Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
5 Questions with Bulisani Khumalo
read more
Resource type: Blog Posts
Mobile app provides convenient information for health workers managing people with Advanced HIV Disease
CHAI in partnership with Infectious Diseases Institute (IDI) through the Unitaid-CHAI AHD Initiative Enhanced Partner Network has developed an open access mobile application for healthcare workers to support the rollout of the World Health Organization (WHO) recommended package of care for people with Advanced HIV Disease.
3 ways to close the HIV equity gap on World AIDS Day 2022
World AIDS Day 2022 is an opportunity to celebrate achievements in the fight against HIV – and reflect on how far we still have to go. This year’s theme, Equalize, highlights the critical need to address inequalities that are limiting progress. At CHAI, we are working...
How CHAI and Unitaid are helping countries like Nigeria build a future free of cervical cancer
To mark the World Health Organization’s second anniversary of Cervical Cancer Elimination Day of Action today, CHAI looks at the impact of its cervical cancer program in Nigeria
Missing Billion report proposes a pathway to close ‘major health gap’ for adults and children with disabilities
The Missing Billion Initiative and Clinton Health Access Initiative have published their Reimagining Health Systems that Expect, Accept and Connect 1 billion people with Disabilities Report.
5 Questions with Rampone Mochekele
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Empowering disabled children to play via early access to assistive technology
Around the world, 2.5 billion people need assistive products and services. Yet nearly one billion of them are denied access, particularly in low- and middle-income countries, where access can be as low as 3 percent of the need for these life-changing products. For...
Understanding manufacturing and cost for HIV prevention game changer: generic CAB-LA COGS analysis and FAQ brief
As part of a growing portfolio of biomedical HIV prevention options, long-acting injectable cabotegravir (CAB-LA) was approved by the US FDA in December 2021. Evidence from two clinical trials, HPTN 083 and HPTN 084, which enrolled nearly 8,000 participants across 13...
Meet the Digital Health team
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Best-in-class second-line HIV treatment rolls out in Zambia and Nigeria
A critical second-line HIV treatment called darunavir/ritonavir (DRV/r) is rolling out across Nigeria and Zambia – some of the earliest adopters of many countries that can now access an affordable supply of these medicines following a pricing agreement secured by CHAI and Unitaid last year.